unilabs.com Our Company Areas of Expertise Our Network Investors People News & Media News News & Media News Press Review Unilabs announces the resignation of its CFO and a new Chief Financial Officer 9/5/2014 Geneva, Switzerland, September 5, 2014 – Unilabs, a leading medical diagnostic services company, announces today that Raffi Asadorian, Chief Financial Officer since 2009 has notified the Company of his resignation effective September 30, 2014, to pursue other opportunities. Karl Erik Clausen will succeed Raffi as Unilabs’s new Chief Financial Officer. Karl Erik will start in his new position on October 6, 2014. Raffi will serve in an advisory capacity through the end of the year to ensure a smooth transition to the new CFO. Karl Erik has more than 15 years of international experience as a CFO, 10 of which in healthcare. He joins from Bio Products Laboratory in the UK, where he was both CFO and COO. Prior to that, Karl Erik held the role of CFO at Octapharma, where he was also responsible for the Plasma Production division in the US. Jos Lamers, Chief Executive Officer of Unilabs, said: "We would like to welcome Karl Erik in his new role – he has extensive experience in our sector and we are confident that he will be instrumental in helping us drive further growth at Unilabs. “On behalf of the Company and its shareholders, I would like to thank Raffi for his tireless commitment and his invaluable contribution to the development of Unilabs over the last five years. We are sorry to see Raffi go and are grateful for his ongoing assistance and wish him well in his future endeavours. He leaves us with an experienced financial team in place that will help ensure a seamless transition under new financial leadership." Raffi Asadorian, Chief Financial Officer of Unilabs, noted: "I very much appreciated the opportunity to serve as Chief Financial Officer of Unilabs during the last five years. We have been successful in building a strong Company in a dynamic industry. I look forward to watching the Company continue to grow and thrive with the foundations and management team that are in place.” Karl Erik Clausen, incoming Chief Financial Officer of Unilabs, added: “I look forward to joining Unilabs. I am delighted to bring my international finance and operational experience together to assist with driving forward the business.” About Unilabs: We are one of Europe’s leading providers of clinical laboratory testing and medical diagnostic imaging services to private and public healthcare providers, local governments, insurance companies, pharmaceutical companies and the general public. We operate laboratory and medical diagnostic imaging facilities in 12 countries: Denmark, Finland, France, Italy, Norway, Peru, Portugal, Russia, Spain, Sweden, Switzerland and the United Kingdom. Our network of facilities provides us with one of the broadest geographic footprints of any clinical laboratory and medical diagnostic services provider in Europe. For more information about Unilabs, please visit www.unilabs.com. Laboratory Medicine Medical Imaging Cellular Pathology Reproductive Medicine Drug Development Services Scientific Leadership Find us © UNILABS 2012 OUR COMPANY History Our Commitment Board of Directors Executive Management Team Diagnostics Market Diagnostics Market Leader Unilabs at a Glance A Leader in Outsourcing AREAS OF EXPERTISE Laboratory Medicine Medical Imaging Histopathology Reproductive Medicine Drug Development Services Scientific Leadership OUR NETWORK Locations Headquarters INVESTORS Investor Relations PEOPLE People HR Philosophy Careers NEWS Media & News